Metacognitive Strategy Training for Stroke

Phase 2

Recruiting

Led By Timothy J Wolf, OTD, PhD

Research Sponsored by University of Missouri-Columbia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adults age 40-85

Absence of moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale (NIHSS) aphasia score of 1 or less or documented in acute therapy evaluation

Must not have

Dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment (MoCA)

No voluntary movement in affected upper extremity as indicated by a score of 4 on the NIHSS motor arm score or documented in acute therapy evaluation

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change in baseline to follow-up (12 weeks after post-intervention assessment)

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to improve activity performance and reduce motor impairment in individuals with stroke through metacognitive strategy training.

Who is the study for?

This trial is for adults aged 40-85 who have had a stroke within the last 9 months, can read and write in English, and are living at home (with or without help). They should be able to move their arms somewhat but not fully (mild to moderate arm weakness), and they shouldn't have severe speech problems, depression, dementia, other serious neurological issues or any condition that would make the study unsafe for them.

What is being tested?

The trial tests a new way of rehab called Metacognitive Strategy Training using the CO-OP approach against usual care occupational therapy. It's designed to see if this strategy helps improve daily activities and motor function after a stroke. Participants will get either ten sessions of this new training or regular therapy, with follow-ups before treatment starts, right after it ends, and three months later.

What are the potential side effects?

Since this is an educational intervention focusing on cognitive strategies rather than medication or invasive procedures, significant side effects are not expected. However, participants may experience fatigue or frustration during rehabilitation exercises.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 40 and 85 years old.

Select...

I can speak and understand others without significant difficulty.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with dementia based on my MoCA score.

Select...

I cannot move my arm due to my condition.

Select...

I have severe depression, as shown by my high score on a health questionnaire.

Select...

My medical records show I have a brain-related diagnosis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change in baseline to follow-up (12 weeks after post-intervention assessment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change in baseline to follow-up (12 weeks after post-intervention assessment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and change in baseline to follow-up (12 weeks after post-intervention assessment) for reporting.